AzTrials
AzTrials

Acupuncture, EarPhase 3NCT03534869

Auricular Acupuncture as Effective Pain Relief After Episiotomy

A Phase 3 study testing Ear acupuncture and Analgesics in people with Acupuncture, Ear and Episiotomy; Complications, run by University Hospital Sestre Milosrdnice at 1 site in Croatia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Episiotomy is performed in up to 30% of vaginal deliveries. Previously, pain treatment following episiotomy has relied on non-steroid anti-inflammatory drugs (NSAID) as analgesics, whose use during breastfeeding remains controversial due of their transfer to the child through lactation. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Ear acupuncture and Analgesics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCroatia
Study dates
1 Nov 2016to 30 Apr 2017
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy pregnant women over 18 years of age
  • a minimum of 36 weeks' gestation
  • patients that underwent mediolateral episiotomy during vaginal delivery

Who cannot join

  • any illness diagnosed during pregnancy
  • unwillingness to submit to acupuncture therapy

Trial locations and contacts

1 site in 1 country.

Croatia1 site
  • University Hospital Center Sestre milosrdnice

    Zagreb, 10000

Other trials in Croatia

About this study

Official title: Auricular Acupuncture as Effective Pain Relief After Episiotomy: A Prospective Interventional Randomized Parallel Single-center Study

Background: Episiotomy is performed in up to 30% of vaginal deliveries. Previously, pain treatment following episiotomy has relied on non-steroid anti-inflammatory drugs (NSAID) as analgesics, whose use during breastfeeding remains controversial due of their transfer to the child through lactation. The aim of the study is to determine the effect of acupuncture on postpartal perineal pain following episiotomy.

Methods: The study is designed as a prospective interventional randomized parallel single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy. The population will encompass 60 patients that have had mediolateral episiotomy performed during vaginal delivery, with 29 receiving acupuncture therapy and 31 not receiving acupuncture therapy for pain relief. NSAID analgesic therapy will be made available per request.

Read the detailed description

Study Protocol The study is designed as a prospective interventional randomized parallel longitudinal single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy conducted in the Department of Gynecology and Obstetrics, University Hospital Center Sestre milosrdnice, Zagreb, Croatia. This institution performs up to 3100 deliveries per year. Episiotomy is indicated and performed in 30% of them.

Prospective data will be collected from November 2016 to April 2017. The study will include healthy pregnant women over 18 years of age, a minimum of 36 weeks' gestation that underwent mediolateral episiotomy during vaginal delivery. Sixty patients will be included in the study. Half of patients will be treated with auricular acupuncture for episiotomy pain relief and oral analgesics, while the other half will be treated with oral analgesics only. In both groups, administration of oral analgesics was recorded. The patients will be allocated to the groups by using a heads-tails coin toss.

In this study, auricular acupuncture will be used. The acupuncture treatment consists of three acupuncture needles on the dominant ear according to French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point that is used to increase the anaesthetic effect according to both French and Chinese traditions (14,15). Acupuncture needles will be stimulated by manual rotation of the needle to evoke needle sensation De Qi. No electrostimulation will be used. Sterile 0,2 x 1,4 mm needles were used. The needles will be inserted within 6-8 hours after childbirth by a certified acupuncturist. The needles will be left in place until the hospital discharge of the patient on the third postpartal day, and removed by a certified acupuncturist.

Additional oral analgesics (NSAID) could be supplied at any time upon patients request during hospitalization. Oral ibuprofen would be given as first line therapy, while oral paracetamol would be given as second line therapy.

Primary outcome measures will be pain intensity (VAS score) immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity. Secondary outcome measures will be the need for analgesics, the amount of given analgesics, and the number of analgesic repetitions during the day.

In addition, subjective experiences of postpartum bleeding and pain due to uterine contractions will be recorded. For those who had received acupuncture therapy, pain levels at the acupuncture site, analysis of acupuncture related experience included discomfort during sleep, other contacts with acupuncture previously and likelihood of recommending the method to a friend will be noted. After leaving the hospital, women in the acupuncture group will be asked to fill out a questionnaire on acupuncture treatment satisfaction. All patients will sign an informed consent form. Inter-group comparisons will be performed based on the patient status at the time of hospital admission and during hospital stay. Input parameters: age, education level, number of previous births. Characteristics of delivery will be noted as: the time of birth, the duration of the birth, the subjective experience of the birth, the application of epidural analgesia.

If labor starts before 8 AM, it will be considered as the first day of the hospitalization, and if labor starts later than 8 AM, the first day of hospitalization will be documented as the next day.

Pain intensity will be evaluated using the Visual Analog Scala score. VAS score is scaled from 1 (smallest pain) to 10 (strongest pain). VAS score higher than 3 was the cut-off point for analgesic administration. The patients will be divided into two groups based on their education level; the first group encompassing women who had finished high school, and the other women who hold a university degree.

Statistical analysis The results will be expressed as a number for categorical variables and as a median value (25th-75th interquartile range) for continuous variables. Continuous variables will be compared using the Student's t-test for independent samples, while categorical variables were compared using χ2-test. Fisher's exact test will be used if expected frequencies are less than five. All statistical tests will be two tailed, and P values < 0.05 considered statistically significant. All statistical analyses will be performed using MedCalc 9.5.1.0 (MedCalc Software, Mariakerke, Belgium).

Peer-reviewed publications containing data from the study have not yet been published.

Being tested
Ear acupuncture, Analgesics
Keywords
auricular acupuncture, episiotomy, acupuncture, pain relief, analgesic therapy
Medical subject headings
Labor Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ear acupunctureProcedure or surgery

    Also called Ear, acupuncture

    French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point.

  • AnalgesicsDrug

    Also called Oral analgesics

    Oral ibuprofen was given as first line therapy, while oral paracetamol was given as second line therapy.

Study groups in NCT03534869
Study groupRoleWhat they receive
Ear Acupuncture and Oral AnalgesicsExperimentalThe acupuncture treatment consisted of three acupuncture needles on the dominant ear according to French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point that is used to increase the anaesthetic effect according to both French and Chinese traditions. Additional oral analgesics (NSAID) could be supplied at any time upon patients request during hospitalization. Oral ibuprofen was given as first line therapy, while oral paracetamol was given as second line therapy.
Receives: Procedure: Ear acupuncture
Oral Analgesics OnlyActive comparatorPostoperative standard oral analgesic therapy (NSAID) supplied at any time upon patients request during hospitalization. Oral ibuprofen would be given as first line therapy, while oral paracetamol would be given as second line therapy.
Receives: Drug: Analgesics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain relief

    Level of pain intensity measured by VAS - Visual Analogue Scale score ranging from 1 (smallest pain level) to 10 (highest pain level).

    Measured: Immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity.

Secondary outcomes (3)
  1. Oral analgesics amount

    Amount of given analgesics in miligrams per patient per day during the first 3 postpartal days.

    Measured: First 3 postpartal days.

  2. Postpartum bleeding and pain due to uterine contractions

    Subjective levels of postpartum bleeding and pain due to uterine contractions recorded.

    Measured: First 3 postpartal days.

  3. Number of analgesic repetitions during the day.

    Number of times patients required oral analgesic therapy (N).

    Measured: First 3 postpartal days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2018
  2. Study start1 Nov 2016
  3. Primary completion30 Apr 2017
  4. Study completion30 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study was designed as a prospective interventional randomized parallel longitudinal single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy conducted in the Department of Gynecology and Obstetrics, University Hospital Center Sestre milosrdnice, Zagreb, Croatia. Prospective data were collected from November 2016 to April 2017. The study included healthy pregnant women over 18 years of age, a minimum of 36 weeks gestation that underwent mediolateral episiotomy during vaginal delivery. Sixty patients were included in the study. The patients were allocated either of the groups by using a heads-tails binary result coin toss method. Twenty-nine patients were treated with auricular acupuncture for episiotomy pain relief combined with oral analgesic therapy per request, while 31 patients were treated with oral analgesics per request only. In both groups, administration of oral analgesics was recorded.
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03534869
Sponsor's protocol ID
14280 / 16-4
Status last verified
May 2018
First submitted
30 Apr 2018
Last updated
23 May 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: All statistical data gathered from the study, no identifiable patient records.

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Ear acupuncture and Analgesics in people with Acupuncture, Ear and Episiotomy; Complications, run by University Hospital Sestre Milosrdnice at 1 site in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain relief (time frame: Immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in